| 2 Qualitative and quantitative composition
Updated according to current template. No change in actual information
4.3 Contraindications
Typographical/grammatical updates and addition of warning concerning potential hypersensitivity to excipients.
4.4 Special warnings and precautions for use
Updated in full in line with the more up to date Salofalk 1g Suppository information.
4.5 Interaction with other medicinal products and other forms of interaction
Updated in full in line with the more up to date Salofalk 1g Suppository information.
4.6 Pregnancy and lactation
Updated in full in line with the more up to date Salofalk 1g Suppository information.
4.7 Effects on ability to drive and use machines
Updated to standard phrase; no actual change.
4.8 Undesirable effects
Updated in full in line with the more up to date Salofalk 1g Suppository information.
4.9 Overdose
Updated in full in line with the more up to date Salofalk 1g Suppository information.
5.1 Pharmacodynamic properties
Updated in full in line with the more up to date Salofalk 1g Suppository information.
5.2 Pharmacokinetic properties
Updated in full in line with the more up to date Salofalk 1g Suppository information.
5.3 Preclinical safety data
Updated in full in line with the more up to date Salofalk 1g Suppository information.
6.1 List of excipients
Typographical updates.
10 Date of revision of the text
Added date of approval
|
